Generative AI-Powered Intrapartum Clinical Decision Support Among Healthcare Providers

November 5, 2026 updated by: Delta University for Science and Technology

Generative AI-Powered Intrapartum Clinical Decision Support and Healthcare Providers' Decision-Making Speed, Diagnostic Accuracy, Satisfaction, and Clinical Experience: A Quasi-Experimental Study

Pregnancy and childbirth are uniquely important events in women's lives because they are accompanied by major physical, emotional, and psychological changes. Maternal satisfaction, emotional well-being, and perceptions of childbirth are strongly influenced by the quality of labor management. A woman's childbirth experience is shaped by multiple factors, including communication, autonomy, and active participation in the decision-making process. These factors are widely recognized as important indicators of the quality of maternity care. [1]

Recent demographic changes and global population growth have placed increasing demands on healthcare systems, particularly maternal health services. High birth rates in some regions, combined with shortages of trained healthcare professionals, have created a need for scalable, adaptable, and innovative models of care. In response to these challenges, digital health technologies have emerged as promising tools to enhance the quality of maternity care and support both healthcare providers and pregnant women. [2]

Study Overview

Status

Completed

Conditions

Detailed Description

This single-center, non-randomized, parallel-group quasi-experimental study evaluated a generative AI-powered intrapartum clinical decision-support chatbot among healthcare providers involved in normal labor management.

The study included 427 obstetricians and nurses: 214 in the intervention group and 213 in the control group. Providers in the intervention group used the AI-based Smart Normal Labor application to support clinical assessment and decision-making during routine labor care. Providers in the control group followed conventional institutional care practices without using the application.

The evaluation combined assessments of clinical decision-making performance with provider-reported satisfaction, acceptance, clinical experience, and workflow. It also explored perceived barriers and facilitators to application use in clinical practice. The study focused on provider-level outcomes; maternal and neonatal clinical outcomes were not directly assessed.

Study Type

Interventional

Enrollment (Actual)

427

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dakahlia Governorate
      • Al Mansurah, Dakahlia Governorate, Egypt, 35712
        • Basma wageah Basma

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria

Obstetricians and nurses working in the Labor Kiosk, Obstetrics and Gynecology Department, or Outpatient Gynecology Clinics at Mansoura University Hospital.

Direct involvement in the care and supervision of women in active labor.

At least six months of clinical experience in labor management. For the intervention group: completion of at least two months of training on the generative AI-powered Smart Normal Labor intrapartum chatbot before its use with clinical cases during the intervention.

For the intervention group: use of the generative AI-powered Smart Normal Labor intrapartum chatbot during clinical labor management.

For the control group: provision of routine care without prior use of the study chatbot.

Willingness to participate and provide informed consent.

Exclusion Criteria

Healthcare providers not directly involved in labor management, including administrative staff and laboratory personnel.

Less than six months of clinical experience in labor management.

Being on leave or unavailable during the study period.

Declining participation or not providing informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Generative AI-Powered Intrapartum Chatbot Decision Support Group

Healthcare providers used the generative AI-powered Smart Normal Labor intrapartum chatbot to support clinical assessment, interpretation of labor progress, and clinical decision-making during normal labor management. The chatbot was used alongside routine institutional care practices.

Smart Normal Labor is a mobile application incorporating a generative AI-powered chatbot for healthcare providers. It provides interactive clinical decision support using information entered by providers about labor progress and clinical findings. Its intended functions include supporting interpretation of clinical information and formulation of a management plan.

Other Names:
  • Smart Normal Labor
No Intervention: Routine Care Group

Healthcare providers managed normal labor according to routine institutional care practices without using the generative AI-powered intrapartum chatbot.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to a Confirmed Intrapartum Management Decision
Time Frame: During the assessed intrapartum clinical encounter, from case presentation to confirmation of the management decision ,5 months

Elapsed time, measured in minutes, from admission of the woman in labor to confirmation of a clinical management plan by the healthcare provider. Shorter times indicate faster clinical decision-making.

During the assessed intrapartum clinical encounter, from case presentation to confirmation of the management decision ,5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic Accuracy in Intrapartum Clinical Cases
Time Frame: During the assessed intrapartum clinical encounter, at completion of the diagnostic assessment ,5 months.

Percentage of assessed intrapartum clinical cases in which the healthcare provider's diagnosis agrees with the study-defined reference diagnosis, compared between the AI-supported intervention group and the conventional-care control group. Higher percentages indicate greater diagnostic accuracy.

During the assessed intrapartum clinical encounter, at completion of the diagnostic assessment ,5 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2026

Primary Completion (Actual)

October 25, 2026

Study Completion (Actual)

October 29, 2026

Study Registration Dates

First Submitted

April 4, 2026

First Submitted That Met QC Criteria

July 21, 2026

First Posted (Actual)

July 22, 2026

Study Record Updates

Last Update Posted (Actual)

November 9, 2026

Last Update Submitted That Met QC Criteria

November 5, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe